The pharmacokinetics and cantharides-induced blister fluid levels of norfloxacin were studied after a single 400 mg oral dose. The mean maximum serum level was 1-45 mg/1 and occurred 1-5 h after administration. The serum half-life of norfloxacin was found to be 3-5 h. After 24 h 27 % of the administered dose was recovered in the urine as microbiologically active compound. High urine levels were found. Rapid blister fluid penetration occurred, the maximum level (occur-ring between 2-3 h) was about 1 mg/1. Thereafter the blister fluid level exceeded the serum level, both declining in parallel
complained of mild nausea for the first two days on norfloxacin but this subsided spon-taneously and...
A bioequivalence study of two oral formulations of 400 mg norfloxacin was carried out in 18 healthy ...
A 0.3% ophthalmic solution of norfloxacin (NFLX), one of the new quinolone compounds, was instilled ...
The pharmacokinetics and tissue penetration of four quinolones were studied. The compounds were norf...
For assessing plasma and tissue concentrations of norfloxacin after oral administration, twelve pati...
Bioavailability and pharmacokinetics of two commercially available preparations of norfloxacin i.e. ...
The pharmacokinetics and tissue penetration of five quinolones into inflammatory exudate were studie...
Abstract: The present paper aimed to study the effect of normal availability of norfloxacin in human...
A single 400-mg oral dose of grepafloxacin (OPC-17116) was given to each of six healthy male volunte...
The pharmacokinetic profile of two different formulations of Norfloxacin tablets - 400 mg; as test f...
A high-performance liquid chromatographic analysis with fluorimetric detection is described for the ...
The pharmacokinetics of the 4-quinolone agent, ofloxacin, were studied in six healthy volunteers, fo...
The pharmacokinetics of ofloxacin were studied in six healthy volunteers following a 600 mg oral dos...
Two levofloxacin administration regimens were used for six healthy male volunteers. They received ei...
A bioequivalence study of two oral formulations of 400 mg norfloxacin was carried out in 18 healthy ...
complained of mild nausea for the first two days on norfloxacin but this subsided spon-taneously and...
A bioequivalence study of two oral formulations of 400 mg norfloxacin was carried out in 18 healthy ...
A 0.3% ophthalmic solution of norfloxacin (NFLX), one of the new quinolone compounds, was instilled ...
The pharmacokinetics and tissue penetration of four quinolones were studied. The compounds were norf...
For assessing plasma and tissue concentrations of norfloxacin after oral administration, twelve pati...
Bioavailability and pharmacokinetics of two commercially available preparations of norfloxacin i.e. ...
The pharmacokinetics and tissue penetration of five quinolones into inflammatory exudate were studie...
Abstract: The present paper aimed to study the effect of normal availability of norfloxacin in human...
A single 400-mg oral dose of grepafloxacin (OPC-17116) was given to each of six healthy male volunte...
The pharmacokinetic profile of two different formulations of Norfloxacin tablets - 400 mg; as test f...
A high-performance liquid chromatographic analysis with fluorimetric detection is described for the ...
The pharmacokinetics of the 4-quinolone agent, ofloxacin, were studied in six healthy volunteers, fo...
The pharmacokinetics of ofloxacin were studied in six healthy volunteers following a 600 mg oral dos...
Two levofloxacin administration regimens were used for six healthy male volunteers. They received ei...
A bioequivalence study of two oral formulations of 400 mg norfloxacin was carried out in 18 healthy ...
complained of mild nausea for the first two days on norfloxacin but this subsided spon-taneously and...
A bioequivalence study of two oral formulations of 400 mg norfloxacin was carried out in 18 healthy ...
A 0.3% ophthalmic solution of norfloxacin (NFLX), one of the new quinolone compounds, was instilled ...